KRISTEN HOLLOWAY: Open Payments
NPI 1972086296 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 24 payments from 12 companies in 2025. Trend: 2023 $533 · 2024 $675 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| ABBVIE INC. | 3 | $62 |
| Corcept Therapeutics | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 1 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $28 |
| Amgen Inc. | 2 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| PFIZER INC. | 1 | $20 |
Products named: Kerendia, Ozempic, VRAYLAR, Rybelsus, Korlym, VOQUEZNA, Cresemba, XIFAXAN.
Industry payments across AL — which companies pay providers there.
